
Nephrotoxic care can be improved with better risk score assessment and provider education.
Erin Hunter is an assistant editor at Pharmacy Times®. She is a proud alumna of the University of Massachusetts. She graduated with degrees in Journalism, Art History, and Environmental Conservation.
Nephrotoxic care can be improved with better risk score assessment and provider education.
Improvements in AI could change the way pharmacists and providers interact with, and care for, patients.
Pharmacy Times will be at the American Society for Nephrology’s (ASN) 2023 Kidney Week Annual Meeting in Philadelphia, Pennsylvania, from November 2 to 5.
Routine screenings for C diff on admission to the hospital could possibly prevent C diff transmission in the hospital setting.
The biosimilar, now legally available at the pharmacy level, demonstrated similar safety, purity, and potency to the reference product.
This “refreshing alternative” to calorie restriction does not include calorie counting, yet it is naturally associated with greater energy restriction compared to the latter.
Patients who are immunocompromised generally had worse risk and severity of CDI.
However, uncomplicated diabetes was not significantly linked to a greater risk of all-cause mortality or death from colorectal cancer.
With a new administration protocol created specifically for the routine clinic, infectious disease physicians can treat recurrent clostridioides difficile infection in less than 3 weeks.
Semaglutide was found to be the most effective drug for weight loss, but the benefits may not outweigh the cost associated with treatment.
The drug’s mode of action is different than other types of corticosteroids because it’s based in the differential effects on glucocorticoid and mineralocorticoid receptors.
This is the first phase 3 trial to evaluate a KRAS G12C-inhibitor plus an anti-epidermal growth factor receptor antibody for this type of colorectal cancer.
The novel combination met the co-primary endpoints of progression-free survival and overall survival during the CheckMate -901 trial, also demonstrating sizeable improvement in objective response.
The fast pace of information can make it difficult to efficiently apply data to care.
Women with HIV reported higher rates of physical abuse than men with HIV, but women had more social support from family and friends.
In a recent study, approximately 99% of children who received solid organ transplant and live vaccination against rubella had antibodies 1 to 3 months post-vaccination.
The statistically significant and clinically meaningful improvement in disease-free survival is “practice-changing” and may represent a “paradigm shift” in treatment, according to experts.
Biktarvy was found both effective and safe for long-term use in HIV, as well as for patients with mental health conditions.
Following the results of a meta-analysis that reviewed biosimilar trial design and endpoints, investigators urge for greater biosimilar uptake initiatives.
In a recent study, 97% of patients had to wait a day before receiving their prescription, and this may worsen the risk of hospitalization.
A subcutaneous injection of ocrelizumab was markedly effective at suppressing brain lesions in patients with multiple sclerosis, according to data from a phase 3 trial.
TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of the EGFR signaling pathway.
Investigators suggest that the Bacille Calmette–Guérin vaccine, which prevented tuberculosis in nonhuman primates infected with SIV, can also protect against HIV.
Health promotional strategies should account for social contexts and cultural perspectives to increase the number of individuals who choose to test for HIV.
Pre-exposure prophylaxis found to provide peace of mind for patients at risk of HIV, and coupled with frequent HIV testing in the health care setting, lowers the perceived risk of contracting the disease.
Primary care physicians, particularly in family medicine, offer PrEP at a significantly low rate, despite US Preventive Services Task Force recommendations.
Investigators hope that continued research and addressing disparities can improve equitable access to asthma treatments for all pediatric patients.
Community pharmacies are ideal locations to identify and recruit underrepresented patients for clinical trials.
Within this care model, pharmacists can serve an important role in caring for patients, whether it is identifying adverse medication interactions or pushing patients to seek additional support.
Providing clinical trials at community locations allows patients with travel restrictions to access novel treatments that are typically studied academic institutions.